Welcome from the Director

Dear Colleagues,

We are pleased to invite you to the 3rd Annual Testosterone Therapy and Men’s Health Congress, taking place 6–7 November 2026 in Copenhagen, Denmark.

As interest in testosterone therapy and men’s health continues to expand worldwide, this year’s Congress will bring together an international faculty of leading experts to discuss the latest scientific evidence, emerging therapies, and practical clinical applications that are shaping patient care.

The comprehensive two-day program will explore a wide range of topics, including testosterone deficiency, sexual medicine, fertility preservation, cardiovascular outcomes, GLP-1 receptor agonists, prostate cancer, hormone therapy in women, transgender health, and the evolving role of hormone therapy across the lifespan. Through expert presentations, case-based discussions, and interactive question-and-answer sessions, participants will gain valuable insights that can be immediately applied in clinical practice.

We are also pleased to announce that the Congress has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME^®) for 10 European CME credits (ECMEC^®s).

Building on the success of our previous meetings, we are delighted to bring the Congress to Copenhagen, allowing us to welcome a larger and more diverse international audience while fostering meaningful collaboration among clinicians, researchers, and healthcare professionals dedicated to advancing men’s health.

We look forward to welcoming you to Copenhagen.

Sincerely,
Abraham Morgentaler, MD, FACS
Course Director